Metabolomics

World Market Report

MCP-6954

EXECUTIVE ENGAGEMENTS

POOL

2101
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

378
Interactions with Platform & by Email

PARTICIPANTS

63
Unique # Participated

VALIDATIONS

19
Responses Validated*

COMPANIES

31
Responses Validated*
* Login for a full stack data experience

DATE

OCT 2022

TABLES

202

PAGES

268

EDITION

16

PRICE

USD 5600

CODE

MCP-6954


COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)

RANK

(S/A/N/T)

%

VALIDATED RESEARCH *

* S = Strong; A = Active; N = Niche; T= Trivial (<1%)
* Login to Participate & View Data Stacks
* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlassTM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.
View All Companies...

PARTICIPATE NOW!
RESEARCH MODULES EXECUTIVES
  

HIGHLIGHTS & REPORT INDEX

What's New for 2022?

» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year

Global Metabolomics Market to Reach $5 Billion by 2027
In the changed post COVID-19 business landscape, the global market for Metabolomics estimated at US$2.2 Billion in the year 2020, is projected to reach a revised size of US$5 Billion by 2027, growing at a CAGR of 12.8% over the analysis period 2020-2027. Biomarker Discovery, one of the segments analyzed in the report, is projected to record a 14.3% CAGR and reach US$2 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Drug Discovery segment is readjusted to a revised 12.8% CAGR for the next 7-year period.

The U.S. Market is Estimated at $637.9 Million, While China is Forecast to Grow at 12.2% CAGR
The Metabolomics market in the U.S. is estimated at US$637.9 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$871.6 Million by the year 2027 trailing a CAGR of 12.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.4% and 10.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9.2% CAGR.

Toxicology Testing Segment to Record 11.5% CAGR
In the global Toxicology Testing segment, USA, Canada, Japan, China and Europe will drive the 11.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$293.6 Million in the year 2020 will reach a projected size of US$623 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.

SELECT PLAYERS

AB Sciex LLC; African Biosciences Ltd; Agilent Technologies, Inc.; Agios Pharmaceuticals, Inc.; Berg LLC; BioCat GmbH; Biocenter Finland; Biocrates Life Sciences AG; Biogenetics; Bio-Rad Laboratories, Inc.

SEGMENTS

» Application (Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics, Other Applications) » End-Use (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Other End-Uses)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Metabolomics - The Current Spotlight of "Omics" Toolbox
Application Areas
Metabolomics in Cancer Detection
Growth Drivers
Market Barriers & Challenges
Recent Market Activity
Metabolomics: A Regional Perspective
US and Europe Spearhead the Global Metabolomics Market
Asia-Pacific: The Fastest Growing Metabolomics Market
Biotechnology and Pharmaceutical Sectors Drive Metabolomics Research
Demand for Data Analysis Tools and Software on Rise
Bioinformatics-based Metabolomics Applications Poised to Grow
List of Select Metabolomic Analysis Software
Metabolomics in Forensics and PMI Analysis
Metabolomics Research Provides New Tools to Understand Human Health
Techniques to Examine Metabolites
Understanding Human Health and Predicting Disease Risk
Causality Assessment
NMR-based Metabolomics Screens Desirable LAB Strain with Specific Fermentation Characteristics
NMR-based Metabolomics
Metabolomics Laboratory Management Systems (LIMS): Growing in Significance
Synopsis of Select Metabolomic Databases
Some Examples of Metabolomics LIMS
Targeted Metabolomics in Newborn Screening: An Area of Success
Lack of Standardization - A Prime Concern
Metabolomics – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
AB SCIEX (USA)
Agilent Technologies, Inc. (USA)
Biocrates Life Sciences AG (Austria)
Metanomics GmbH (Germany)
Bio-Rad Laboratories, Inc. (USA)
Bruker Corporation (USA)
Chenomx, Inc. (Canada)
Human Metabolome Technologies, Inc. (Japan)
LECO Corporation (USA)
Metabolon, Inc. (USA)
Shimadzu Corporation (Japan)
SiDMAP, LLC (USA)
Thermo Fisher Scientific, Inc. (USA)
Waters Corporation (USA)
3. MARKET TRENDS & DRIVERS
High Performance Liquid Chromatography (HPLC) Dominates the Market
Major Trends in Gas Chromatography: A Quick Review
Advances in GC Technology
Hyphenated Technologies: Order of the Day
Liquid Chromatography Gains Space in Metabolomics Analysis
MS Systems with UHPLC: A Novel Fusion
HILIC Systems Soaring in Popularity
Capillary Electrophoresis Gains Prominence
4. GLOBAL MARKET PERSPECTIVE
World Metabolomics Market Analysis of Annual Sales in US$ Thousand for Years 2012 through 2027
World Recent Past, Current & Future Analysis for Metabolomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Metabolomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Metabolomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Biomarker Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Biomarker Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Biomarker Discovery by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Drug Discovery by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Toxicology Testing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Nutrigenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Nutrigenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Nutrigenomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Functional Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Functional Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Functional Genomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Pharmaceutical & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Pharmaceutical & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Pharmaceutical & Biotechnology Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Contract Research Organizations by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
UNITED STATES
Metabolomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
USA Recent Past, Current & Future Analysis for Metabolomics by Application - Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Metabolomics by Application - Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Metabolomics by Application - Percentage Breakdown of Value Revenues for Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications for the Years 2012, 2021 & 2027
USA Recent Past, Current & Future Analysis for Metabolomics by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Metabolomics by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Metabolomics by End-Use - Percentage Breakdown of Value Revenues for Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses for the Years 2012, 2021 & 2027
CANADA
Canada Recent Past, Current & Future Analysis for Metabolomics by Application - Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Metabolomics by Application - Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Metabolomics by Application - Percentage Breakdown of Value Revenues for Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications for the Years 2012, 2021 & 2027
Canada Recent Past, Current & Future Analysis for Metabolomics by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Metabolomics by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Metabolomics by End-Use - Percentage Breakdown of Value Revenues for Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses for the Years 2012, 2021 & 2027
JAPAN
Metabolomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
Japan Recent Past, Current & Future Analysis for Metabolomics by Application - Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Metabolomics by Application - Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Metabolomics by Application - Percentage Breakdown of Value Revenues for Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications for the Years 2012, 2021 & 2027
Japan Recent Past, Current & Future Analysis for Metabolomics by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Metabolomics by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Metabolomics by End-Use - Percentage Breakdown of Value Revenues for Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses for the Years 2012, 2021 & 2027
CHINA
Metabolomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
China Recent Past, Current & Future Analysis for Metabolomics by Application - Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Metabolomics by Application - Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Metabolomics by Application - Percentage Breakdown of Value Revenues for Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications for the Years 2012, 2021 & 2027
China Recent Past, Current & Future Analysis for Metabolomics by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Metabolomics by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Metabolomics by End-Use - Percentage Breakdown of Value Revenues for Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses for the Years 2012, 2021 & 2027
EUROPE
Metabolomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
Europe Recent Past, Current & Future Analysis for Metabolomics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe Historic Review for Metabolomics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Metabolomics by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2021 & 2027
Europe Recent Past, Current & Future Analysis for Metabolomics by Application - Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Metabolomics by Application - Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Metabolomics by Application - Percentage Breakdown of Value Revenues for Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications for the Years 2012, 2021 & 2027
Europe Recent Past, Current & Future Analysis for Metabolomics by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Metabolomics by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Metabolomics by End-Use - Percentage Breakdown of Value Revenues for Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses for the Years 2012, 2021 & 2027
FRANCE
Metabolomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
France Recent Past, Current & Future Analysis for Metabolomics by Application - Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Metabolomics by Application - Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Metabolomics by Application - Percentage Breakdown of Value Revenues for Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications for the Years 2012, 2021 & 2027
France Recent Past, Current & Future Analysis for Metabolomics by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Metabolomics by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Metabolomics by End-Use - Percentage Breakdown of Value Revenues for Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses for the Years 2012, 2021 & 2027
GERMANY
Metabolomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
Germany Recent Past, Current & Future Analysis for Metabolomics by Application - Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Metabolomics by Application - Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Metabolomics by Application - Percentage Breakdown of Value Revenues for Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications for the Years 2012, 2021 & 2027
Germany Recent Past, Current & Future Analysis for Metabolomics by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Metabolomics by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Metabolomics by End-Use - Percentage Breakdown of Value Revenues for Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses for the Years 2012, 2021 & 2027
ITALY
Italy Recent Past, Current & Future Analysis for Metabolomics by Application - Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Metabolomics by Application - Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Metabolomics by Application - Percentage Breakdown of Value Revenues for Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications for the Years 2012, 2021 & 2027
Italy Recent Past, Current & Future Analysis for Metabolomics by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Metabolomics by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Metabolomics by End-Use - Percentage Breakdown of Value Revenues for Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses for the Years 2012, 2021 & 2027
UNITED KINGDOM
Metabolomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
UK Recent Past, Current & Future Analysis for Metabolomics by Application - Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Metabolomics by Application - Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Metabolomics by Application - Percentage Breakdown of Value Revenues for Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications for the Years 2012, 2021 & 2027
UK Recent Past, Current & Future Analysis for Metabolomics by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Metabolomics by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Metabolomics by End-Use - Percentage Breakdown of Value Revenues for Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses for the Years 2012, 2021 & 2027
REST OF EUROPE
Rest of Europe Recent Past, Current & Future Analysis for Metabolomics by Application - Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Metabolomics by Application - Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Metabolomics by Application - Percentage Breakdown of Value Revenues for Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications for the Years 2012, 2021 & 2027
Rest of Europe Recent Past, Current & Future Analysis for Metabolomics by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Metabolomics by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Metabolomics by End-Use - Percentage Breakdown of Value Revenues for Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses for the Years 2012, 2021 & 2027
ASIA-PACIFIC
Metabolomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
Asia-Pacific Recent Past, Current & Future Analysis for Metabolomics by Application - Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Metabolomics by Application - Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Metabolomics by Application - Percentage Breakdown of Value Revenues for Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications for the Years 2012, 2021 & 2027
Asia-Pacific Recent Past, Current & Future Analysis for Metabolomics by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Metabolomics by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Metabolomics by End-Use - Percentage Breakdown of Value Revenues for Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses for the Years 2012, 2021 & 2027
REST OF WORLD
Rest of World Recent Past, Current & Future Analysis for Metabolomics by Application - Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Metabolomics by Application - Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Metabolomics by Application - Percentage Breakdown of Value Revenues for Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications for the Years 2012, 2021 & 2027
Rest of World Recent Past, Current & Future Analysis for Metabolomics by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Metabolomics by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Metabolomics by End-Use - Percentage Breakdown of Value Revenues for Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses for the Years 2012, 2021 & 2027

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com